Search

Supplemental material, sj-pdf-1-jcb-10.1177_0271678X231161207 for Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats by Laura Aguado, Ana Joya, Maider Garbizu, Sandra Plaza-García, Leyre Iglesias, María Isabel Hernández, María Ardaya, Naroa Mocha, Vanessa Gómez-Vallejo, Unai Cossio, Makoto Higuchi, Alfredo Rodríguez-Antigüedad, Mari Mar Freijo, María Domercq, Carlos Matute, Pedro Ramos-Cabrer, Jordi Llop and Abraham Martín in Journal of Cerebral Blood Flow & Metabolism

Supplemental material, sj-pdf-2-jcb-10.1177_0271678X231161207 for Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats by Laura Aguado, Ana Joya, Maider Garbizu, Sandra Plaza-García, Leyre Iglesias, María Isabel Hernández, María Ardaya, Naroa Mocha, Vanessa Gómez-Vallejo, Unai Cossio, Makoto Higuchi, Alfredo Rodríguez-Antigüedad, Mari Mar Freijo, María Domercq, Carlos Matute, Pedro Ramos-Cabrer, Jordi Llop and Abraham Martín in Journal of Cerebral Blood Flow & Metabolism

Supplemental material, sj-pdf-1-jcb-10.1177_0271678X231161207 for Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats by Laura Aguado, Ana Joya, Maider Garbizu, Sandra Plaza-García, Leyre Iglesias, María Isabel Hernández, María Ardaya, Naroa Mocha, Vanessa Gómez-Vallejo, Unai Cossio, Makoto Higuchi, Alfredo Rodríguez-Antigüedad, Mari Mar Freijo, María Domercq, Carlos Matute, Pedro Ramos-Cabrer, Jordi Llop and Abraham Martín in Journal of Cerebral Blood Flow & Metabolism

Supplemental material, sj-pdf-2-jcb-10.1177_0271678X231161207 for Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats by Laura Aguado, Ana Joya, Maider Garbizu, Sandra Plaza-García, Leyre Iglesias, María Isabel Hernández, María Ardaya, Naroa Mocha, Vanessa Gómez-Vallejo, Unai Cossio, Makoto Higuchi, Alfredo Rodríguez-Antigüedad, Mari Mar Freijo, María Domercq, Carlos Matute, Pedro Ramos-Cabrer, Jordi Llop and Abraham Martín in Journal of Cerebral Blood Flow & Metabolism

31 p.-12 fig.-1 tab. We dedicate this paper to Takashi Umekawa, who generated the HI model at the Karolinska Institute, and unfortunately passed away in 2018., Microglial phagocytosis of apoptotic debris prevents buildup damage of neighbor neurons and inflammatory responses. Whereas microglia are very competent phagocytes under physiological conditions, we report their dysfunction in mouse and preclinical monkey models of stroke (macaques and marmosets) by transient occlusion of the medial cerebral artery (tMCAo). By analyzing recently published bulk and single cell RNA sequencing databases, we show that the phagocytosis dysfunction was not explained by transcriptional changes. In contrast, we demonstrate that the impairment of both engulfment and degradation was related to energy depletion triggered by oxygen and nutrient deprivation (OND), which led to reduced process motility, lysosomal exhaustion, and the induction of a protective macroautophagy/autophagy response in microglia. Basal autophagy, in charge of removing and recycling intracellular elements, was critical to maintain microglial physiology, including survival and phagocytosis, as we determined both in vivo and in vitro using pharmacological and transgenic approaches. Notably, the autophagy inducer rapamycin partially prevented the phagocytosis impairment induced by tMCAo in vivo but not by OND in vitro, where it even had a detrimental effect on microglia, suggesting that modulating microglial autophagy to optimal levels may be a hard to achieve goal. Nonetheless, our results show that pharmacological interventions, acting directly on microglia or indirectly on the brain environment, have the potential to recover phagocytosis efficiency in the diseased brain. We propose that phagocytosis is a therapeutic target yet to be explored in stroke and other brain disorders and provide evidence that it can be modulated in vivo using rapamycin. Abbreviations: AIF1/IBA1: allograft inflammatory factor 1; AMBRA1: autophagy/beclin 1 regulator 1; ATG4B: autophagy related 4B, cysteine peptidase; ATP: adenosine triphosphate; BECN1: beclin 1, autophagy related; CASP3: caspase 3; CBF: cerebral blood flow; CCA: common carotid artery; CCR2: chemokine (C-C motif) receptor 2; CIR: cranial irradiation; Csf1r/v-fms: colony stimulating factor 1 receptor; CX3CR1: chemokine (C-X3-C motif) receptor 1; DAPI: 4’,6-diamidino-2-phenylindole; DG: dentate gyrus; GO: Gene Ontology; HBSS: Hanks’ balanced salt solution; HI: hypoxia-ischemia; LAMP1: lysosomal-associated membrane protein 1; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; MCA: medial cerebral artery; MTOR: mechanistic target of rapamycin kinase; OND: oxygen and nutrient deprivation; Ph/A coupling: phagocytosis-apoptosis coupling; Ph capacity: phagocytic capacity; Ph index: phagocytic index; SQSTM1: sequestosome 1; RNA-Seq: RNA sequencing; TEM: transmission electron microscopy; tMCAo: transient medial cerebral artery occlusion; ULK1: unc-51 like kinase 1. © 2023 The Author(s)., This work was supported by grants from the Spanish Ministry of Science and Innovation Competitiveness MCIN/AEI/10.13039/501100011033 (https://www.ciencia.gob.es/) and ERDF “A way to make Europe” (RTI2018-099267-B-I00 and RYC-2013-12817 to AS; RTI2018–097948-A-100 and RYC-2016–20480 to OP), a Tatiana Foundation Award (P-048-FTPGB 2018) to AS a Basque Government Department of Education project (PIBA 2020_1_0030; http://www.euskadi.eus/basque-government/department-education/) to AS, a Basque Government Department of Economic development, Sustainability and environment (ELKARTEK KK-2020/00034; https://www.spri.eus/en/) to ECZ, and . SB is recipient of predoctoral fellowship from the Spanish Ministry of Economy and Competitiveness, and VST is recipient of predoctoral fellowship from the Basque Government.